Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Agilon Health (AGL) Operating Expenses (2020 - 2025)

Agilon Health's Operating Expenses history spans 6 years, with the latest figure at $1.8 billion for Q4 2025.

  • For Q4 2025, Operating Expenses rose 8.14% year-over-year to $1.8 billion; the TTM value through Dec 2025 reached $6.4 billion, up 0.68%, while the annual FY2025 figure was $6.4 billion, 0.68% up from the prior year.
  • Operating Expenses reached $1.8 billion in Q4 2025 per AGL's latest filing, up from $1.6 billion in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $1.8 billion in Q4 2025 to a low of $177.0 million in Q4 2021.
  • Average Operating Expenses over 5 years is $1.1 billion, with a median of $1.1 billion recorded in 2023.
  • Peak YoY movement for Operating Expenses: crashed 50.94% in 2021, then soared 187.93% in 2023.
  • A 5-year view of Operating Expenses shows it stood at $177.0 million in 2021, then surged by 139.48% to $423.8 million in 2022, then skyrocketed by 187.93% to $1.2 billion in 2023, then skyrocketed by 33.61% to $1.6 billion in 2024, then rose by 8.14% to $1.8 billion in 2025.
  • Per Business Quant, the three most recent readings for AGL's Operating Expenses are $1.8 billion (Q4 2025), $1.6 billion (Q3 2025), and $1.5 billion (Q2 2025).